| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.79B | 2.69B | 2.63B | 2.59B | 2.36B |
| Gross Profit | 1.54B | 1.49B | 1.43B | 1.43B | 1.32B |
| EBITDA | 711.73M | 810.58M | 786.74M | 771.62M | 703.55M |
| Net Income | 484.47M | 467.28M | 487.49M | 513.10M | 454.37M |
Balance Sheet | |||||
| Total Assets | 5.06B | 6.00B | 5.25B | 3.82B | 3.79B |
| Cash, Cash Equivalents and Short-Term Investments | 108.44M | 115.95M | 115.68M | 163.46M | 299.97M |
| Total Debt | 2.00B | 2.32B | 1.86B | 860.45M | 951.55M |
| Total Liabilities | 2.87B | 3.07B | 2.65B | 1.53B | 1.63B |
| Stockholders Equity | 3.04B | 2.93B | 2.60B | 2.29B | 2.16B |
Cash Flow | |||||
| Free Cash Flow | 661.12M | 491.78M | 606.70M | 461.70M | 507.62M |
| Operating Cash Flow | 719.17M | 556.19M | 641.28M | 513.13M | 545.93M |
| Investing Cash Flow | -26.69M | -844.40M | -1.44B | -222.76M | -33.17M |
| Financing Cash Flow | -706.43M | 294.50M | 750.51M | -416.01M | -422.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $13.28B | 27.78 | 16.21% | 1.67% | 3.78% | 4.85% | |
78 Outperform | $13.71B | 28.27 | 19.45% | 1.32% | 2.85% | 3.09% | |
75 Outperform | $13.26B | 28.01 | 12.21% | 1.60% | 7.09% | -2.29% | |
72 Outperform | $15.06B | 29.09 | 17.85% | 0.82% | 8.01% | 2.67% | |
71 Outperform | $10.80B | 33.89 | 18.09% | 0.50% | -0.37% | 21.77% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | $9.12B | 27.56 | 12.38% | ― | 5.52% | 9.03% |
Nordson Corporation reported record results for the fourth quarter and fiscal year 2025, with sales reaching $752 million in the fourth quarter and $2.8 billion for the full year, marking a 1% and 4% increase respectively over the prior year. The company achieved a 9% increase in adjusted earnings per share for the fourth quarter and a 5% increase for the full year, reflecting strong operational performance despite challenges such as the divestiture of its medical contract manufacturing business. Looking ahead to fiscal 2026, Nordson forecasts sales between $2,830 to $2,950 million and adjusted earnings per share ranging from $10.80 to $11.50, driven by its strategic growth framework and strong backlog.
On October 23, 2025, Nordson Corporation’s Board of Directors approved a new Executive Severance Policy, effective November 1, 2025, to provide severance protections for U.S.-based executive officers in case of employment termination outside a change in control period. This policy outlines conditions under which executives can receive severance benefits, including a lump-sum payment and continued medical coverage, impacting the company’s operations by potentially enhancing executive retention and stability.